Categories: Business

Planning to apply for a Personal Loan? Here are the lesser known reasons for a Personal Loan rejection

Planning to apply for a Personal Loan? Frequent job changes, too many loans, a typo in your application and a missed called could spell trouble. Here are the lesser known reasons for a Personal Loan rejection:

Job-Hopping
Job stability is very important for your lender. Changing jobs every now and then might act as a deterrent during the approval of your loan.

Too Much Credit
You already bear the weight of too many loans on your shoulders. That s a red flag for banks right there.

Typo Trouble
The bank verifies every little detail in your application. A typo causing your flat number to change might just lead to a rejection.

Hello?
You gave your landline number for tele-verification. Unfortunately, you re always at work when they call. Provide your mobile number too.

Alex

Recent Posts

Oasis Calls for CEO Dismissal, Submits Shareholder Proposals for New Directors at Hokuetsu AGM (Securities Code: 3865 JT)

*Oasis proposes dismissal of Hokuetsu CEO Sekio Kishimoto at upcoming AGM * Oasis nominates five…

58 mins ago

Seadrill Announces Two New Drillship Commitments

HAMILTON, Bermuda--(BUSINESS WIRE)--Seadrill Limited (“Seadrill” or the “Company”) (NYSE & OSE: SDRL) today announced contract…

3 hours ago

Kasada Secures #4 Spot on Australia’s Best Workplaces™ in Technology List for 2024

Dedication to Fostering a Culture of Care, Innovation, and Impact Drives Global Growth and Recognition…

3 hours ago

GAMCO Board Declares Special Dividend of $0.20 per share and Regular Quarterly Dividend of $0.04 per share

GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced…

4 hours ago

Coeur to Participate in Upcoming Canaccord Global Metals & Mining Conference

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) Senior Vice President and Chief…

4 hours ago

LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis

Enstilar® (LEO 90100) showed superiority over Daivobet® ointment in primary and both secondary endpoints in…

6 hours ago